David Risinger
Stock Analyst at Leerink Partners
(4.98)
# 59
Out of 4,712 analysts
70
Total ratings
64.8%
Success rate
32.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Risinger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SCTX Scribe Therapeutics | Initiated Coverage: Buy | $37 | $29.47 | +25.55% | 1 | Aug 18, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $641 → $824 | $793.26 | +3.88% | 59 | Aug 17, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $4 | $1.95 | +105.13% | 10 | Aug 11, 2026 |
Scribe Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $29.47
Upside: +25.55%
Regeneron Pharmaceuticals
Aug 17, 2026
Reiterated: Hold
Price Target: $641 → $824
Current: $793.26
Upside: +3.88%
Tenax Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $4
Current: $1.95
Upside: +105.13%